[Continuous scientific research line] The Institute of Technology Institute of Technology developed and treated Parkinson's disease innovation drugs obtained clinical research permits

Chinese society has entered an elderly society. As a disease that seriously affects the health of the elderly, Parkinson's disease has attracted much attention. At present, the incidence of Parkinson's disease in the age of 60 in China has reached 1%. 5%, and it is still increasing rapidly at a rate of more than 4%per year. Parkinson's patients lack the ability to take autonomous medication, seriously affect the quality of life after illness, and will bring a great burden on society and families.

Professor Wang Qing at the Department of Pharmacy of the College of Engineering and Chemical Engineering has undergone more than ten years of research and developed a long -acting Plack Case Top Skin Patch (23mg: 25cm2) in the treatment of Parkinson's disease at home and abroad. Once, it can significantly improve the compliance of patients and reduce the mental stress and care burden of patient families. At present, the drug has obtained clinical research permits of the State Food and Drug Administration's New Drug Review Center (CDE), which will rely on Guangdong Red Coral Pharmaceuticals to conduct clinical research.

High -end innovative drug preparation research is one of the commandings of technological competition in the international biomedical field. Research institutions and enterprises at home and abroad invested a lot of manpower, material resources and funds every year. The successful development of the Praque Solid Patch has fully showed the scientific research capabilities and technical level of our school in the field of biomedicine, and further established the leading position in the field of domestic translucent preparations in China. To the role of the booster.

News source: Dalian Polytechnic News Network

Edit: Wang Yue

School pair: Yan Yiming Li Yixun

- END -